ArticleJTO clinical and research reports2025

Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902.

Yoko Tsukita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.